FlowMetric, Inc.

04/28/2023

All CROs face the same critical challenge of sample integrity when supporting Multiple Sites for Flow Cytometry. One of the most critical steps is getting the sample to a sophisticated laboratory in a timely fashion and in a way that preserves the sample’s quality and integrity. You must ensure that they are stored at the right temperatures and handled properly along the way...

All CROs face the same critical challenge of sample integrity when supporting Multiple Sites for Flow Cytometry. The most critical step is getting the...

04/28/2023

Here in Philadelphia, a multitude of companies have taken up residence. Many of those companies are working with us on very novel and important platforms, monitoring the efficacy of their approaches to cell and gene therapy. This is probably the fastest growing arena for us in terms of a specific client base. We have a lot of success in the cell and gene therapy arena – with stories to match every bit of our experience.

If you couple Flowmetric’s experience with that of KCAS’s, our approach to the realm of cell and gene therapy, we are perfectly poised to offer these.

10/24/2022

Flowmetric is proud to be sponsoring a series of virtual panel discussions, hosted by Life Sciences PA (LSPA). The title of the series is “Phase to Phase: The Guide to ”.

The recent acquisition of FlowMetric by KCAS Bioanalytical & Biomarker Services highlights the consolidation trend in the (CRO) sector and specifically highlights over 50 years of combined experience between FlowMetric and KCAS. The wealth of knowledge and experience represented in their support of and clients through was the impetus for the series.

The idea was just a perfect opportunity at the right time for LSPA. After agreeing on the idea,and asking FlowMetric if they would like to host the 4-part series, the title “Phase to Phase” was agreed upon, as well as the decision to hold one session per quarter. Click here to learn more:

Learn how to keep flow cytometer instruments clean and why it's important, not only preserving the life of the instrument but also ensuring the quality of daily sample analysis.

09/12/2022

KCAS EXPANDS ITS TRANSATLANTIC PRESENCE WITH THE ACQUISITION OF FRANCE-BASED ACTIVE BIOMARKERS

Sept 12, 2022 5:00 AM Central Standard Time

Kansas City, KS metro — (BUSINESS WIRE) — KCAS Bioanalytical & Biomarker Services (KCAS), a leading bioanalytical contract research organization (CRO), backed by Vitruvian Partners, closed the purchase of Active Biomarkers, located in Lyon, France.

Active Biomarkers is a renowned and laboratory with expertise in , , and .

This acquisition adds world-class bioanalytical expertise and an additional European footprint for large molecule and cell/gene therapy bioassay services.

06/04/2022

We are happy to announce that FlowMetric, Inc. (the newest member of the KCAS Bioanalytical and Biomarker Services family) will be exhibiting this week during and our experts there are ready to talk with you about ! Swing by our booth #506 starting tomorrow during the show in Philadelphia, PA!

03/10/2022

Fresh vs. Frozen: Sample Considerations for Clinical Flow Cytometry
https://bit.ly/3sXdfq0

Explore the considerations for fresh vs frozen samples for clinical flow analysis, & go in-depth about the subtleties in selecting the sample matrix.

02/24/2022

Clinical Advances Fueled by the Covid-19 Pandemic | FlowMetric
https://bit.ly/3vg36X6

Learn more about how drugs, vaccines, and testing tools have advanced throughout the two years of the Covid-19 pandemic and how we can use this information to lessen the impact of future epidemics.

02/07/2022

KCAS , John Bucksath, opens the first day of our 2022 meetings this week in . We're happy to welcome some of the leadership team from FlowMetric, our newest , who are joining us today as we discuss the big plans KCAS has for #2022!

02/07/2022

Flow Cytometry Services | Outsourcing CRO's
https://bit.ly/3HyIv3z

Explore what types of flow cytometry applications are the most outsourced to CROs to ensure the highest quality of data from their samples.

02/03/2022

KCAS Bioanalytical and Biomarker Services, a Vitruvian Partners Portfolio Company, Announces Acquisition of FlowMetric, LLC
https://bit.ly/34riV1D

KCAS Bioanalytical and Biomarker Services, a Vitruvian Partners portfolio Company, announces acquisition of FlowMetric, LLC

01/20/2022

Flow Cytometry Services | Identifying Your CRO Partner
https://bit.ly/32kkyh0

FlowMetric has a proven track record in flow cytometry services expertise across pre-clinical & clinical fields of research, providing flow cytometry solutions for the most complex studies.

01/10/2022

Deciphering Dendritic Cells | Flow Cytometry Approach
https://bit.ly/3qbfQLD

Explore the life of Dendritic Cells (DCs) described through Flow Cytometry, lineage of DCs, therapeutic applications of DCs, DC-based cancer vaccines and future of DC cancer vaccines.

12/13/2021

Optimizing Cell Staining for Flow Cytometry Analysis
https://bit.ly/3GV1XH5

11/29/2021

Quantum Dots- Are they ready for primetime flow cytometry?
https://bit.ly/3FY2esc

Is Quantum Dots (Qdots) ready for primetime flow cytometry? Learn more about advantages for using Qdots for flow cytometry applications.

11/13/2021

Day Two!!! FlowMetric Life Sciences is part of SITC 2021 in Washington D.C.!!! We are having great conversations with immunologists. Stop by BOOTH #712 to learn more about our Flow Cytometry Services.

11/12/2021

FlowMetric Life Sciences is excited to be a part of SITC 2021 in Washington D.C.!!!
Stop by BOOTH #712 to learn more about our Flow Cytometry Services.